Rubella Antibody IgG and IgM
The rubella virus is a single stranded enveloped RNA virus. The virus is the cause of the usually minor and self-limiting disease known as German measles. Before widespread vaccination which began in 1969, German measles was mainly a disease of young children; however, today it is mainly seen in young unvaccinated adults. In 1964-65 in the U.S. there was a pandemic of rubella with an estimated 12.5 million cases; in 2009 there were 3 cases reported to the CDC. Symptoms include fever, malaise, coryza, lymphadenopathy, and a fine maculopapular red rash (rubella means "little red"). When present, the rash usually develops rapidly within a day and fades in two to three days. The virus is transmitted by aerosolized particles (coughing, sneezing, etc), urine, feces and skin lesions. The infection usually resolves without complications within 1-2 weeks; however, it is recommended that all women of childbearing age be tested for antibodies to the rubella virus because viral infection during the first trimester of pregnancy can result in birth defects. The virus can cross the placenta and cause destruction to the fetal capillaries. Children can be born with cataracts, glaucoma, deafness, heart defect, bone disease, or neurological problems due to the disease (Congenital Rubella Syndrome). Children who survive CRS can harbor the virus for months and be an important source of infection, particularly to pregnant females. Antibodies to rubella can be detected by hemagglutination inhibition (HI), complement fixation (CF), indirect hemagglutination (IHA), ELISA, or latex agglutination (LA).
Tests can detect IgG and IgM antibody. Titers usually appear as the rash fades (1 week) and peak at 10–14 days for HI and 2–3 weeks for other techniques. Baseline IgG titers may remain elevated for life. Serological tests are used to determine the immune status of the individual, to diagnose postnatal rubella and occasionally to support the diagnosis of rubella. IgM antibody often disappears within 4–5 weeks but may persist for up to a year, and elevated IgM alone should be correlated with signs or clinical history of concurrent or recent infection; IgG antibody remains for life. Reinfection will induce a rise in IgG levels but no or only very little rise in IgM levels. Rubella IgG titers of ≤1:8 indicate susceptibility and the need for immunization to prevent infection during pregnancy. Titers of >1:32 indicate immunity from prior infection or vaccination. Demonstration of a 4-fold rise in titer between acute and convalescent sera may be indicative of a recent infection. Single titers, even >1:256, cannot be interpreted as evidence of recent infection since they are more likely indicative of immune status. The recent resurgence of congenital rubella could largely be prevented with improved rubella testing and vaccination programs.
- Diagnosis of rubella infection
- Prenatal screening for congenital rubella syndrome
- Aid in the assessment of immune status of rubella
Increased in:
- Recent or prior rubella infection
- Congenital rubella infection
- Vaccination (immunity)
- Differentiation of primary infection versus reinfection.
- Spuriously increased IgM antibody occurs in the presence of rheumatoid factor or by cross-reacting antibodies to other viral infections or autoimmune illnesses
If IgM and IgG positive, indicates acute/active infection
If only IgG positive, indicates immunization or past infection
If only IgM positive might indicate exposure, acute infection and or re-infection
IgG antibody
<5 IU/mL - Negative
5-9 IU/mL – equivocal (repeat in 2-3 weeks if indicated)
>10 IU/mL – positive, indicative of current, or previous exposure or immunization
IgM antibody
<0.9 Index value - Negative
0.9 – 1.0 Index value– Equivocal (repeat in 2-3 weeks if indicated)
>1.0 Index value – Positive, indicative of current/active infection, or exposure
Chemiluminescent immunoassay, hemagglutination inhibition (HI), complement fixation (CF), indirect hemagglutination (IHA), enzyme-linked immunosorbent assay (ELISA), latex agglutination (LA).
Serum Red top preferred, Serum gel (SST) acceptable, cerebrospinal fluid collected in a sterile tube.
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 60 days
CSF: Ambient unacceptable
- MMWR Morb Mortal Wkly Rep. 2008 Oct 31;57(43):1176-9. [PMID: 18971920]
- Epidemiol Rev. 2006;28:81. [PMID: 16775038]
- Stevens CD. Clinical Immunology & Serology A Laboratory Perspective 3rd edition. Philadelphia: F.A. Davis Company (2010).
- Murray PR et al (editors): Manual of Clinical Microbiology, 8th ed. ASM Press (2003).